Press

AseBio Celebrates Its 25th Anniversary as a Key Player in the 'Invisible Revolution' That Has Shaped the Development and Growth of Biotechnology in Spain

27/11/2024

Corporate

•  The event, held at the Gran Teatro CaixaBank Príncipe Pío in Madrid, brought together more than 200 attendees, with strong institutional representation.
• With the participation of key figures in AseBio's history, the discussion focused on how the Association has established itself as a catalyst for change, a driving force behind the sector's internationalization, and a fundamental part of the evolution of its regulatory framework.
•  The celebration concluded with the screening of a special video highlighting the crucial role biotechnology plays in our daily lives and how the Association has worked over the past 25 years to make it possible: "The Invisible Revolution."
  
   

AseBio

Financing, a solid ecosystem, and regulation: key challenges for Spain to drive the Bioeconomy forward

21/11/2024

Climate change · Agrifood · Food & feed · Agriculture

• The state of the bioeconomy in Spain was analyzed during a debate sponsored by the European project ShapingBio at the fifth edition of the Green Innovation Forum.
• Organized by AseBio and the Government of Navarra through the public company Sodena, the Green Innovation Forum brought together over 200 professionals from 120 companies at the Baluarte Conference Center in Pamplona.
• On a regulatory and political level, Spain has had the Comprehensive Bioeconomy Strategy in place since 2015, but the reality is that it has not evolved or achieved a significant impact.

AseBio

More than 200 professionals from 120 companies across eight countries gather for the fifth edition of the AseBio Green Innovation Forum

19/11/2024

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy

• The event, organized by AseBio and the Government of Navarra through the public company Sodena, took place this Tuesday at the Baluarte Conference Center in Pamplona.
• Through its sessions, the forum analyzed and debated how biotechnology is an essential tool to address the most pressing challenges of our time.
• The Green Innovation Forum provided a space for creating new business and investment opportunities, facilitated by its partnering platform, which enabled over 200 one-on-one meetings.

AseBio

"25 Years at the Heart of the Sector": AseBio highlights key milestones in an infographic to mark Its 25th anniversary

13/11/2024

Corporate

• Over the past quarter-century, AseBio has led an “invisible revolution,” playing a crucial role in the profound transformation of Spain's biotech sector.
• AseBio’s 25th-anniversary celebration will take place on November 26 at the Gran Teatro CaixaBank Príncipe Pío in Madrid.
• “AseBio has been and will continue to be a catalyst for innovation, so let’s keep working together to ensure that, over the next 25 years, biotechnology remains a cornerstone of our society and a model of sustainable innovation and progress,” stated its president, Rocío Arroyo.

AseBio

Barcelona establishes itself as the host city for BIOSPAIN for the 2025 and 2027 editions

06/11/2024

BioSpain

•  AseBio, in collaboration with Biocat, the Generalitat of Catalonia, and the Barcelona City Council, will host the next two editions of BIOSPAIN in Barcelona, one of Europe’s most important international biotechnology events. This decision reinforces the Catalan capital’s position as a hub for the sector.
• In its 12th edition, the event is expected to gather over 2,000 professionals from more than 1,000 organizations working in health, agri-food, and sustainable industrial solutions from October 7 to 9, 2025, at Fira de Barcelona.
•  Catalonia's BioRegion leads the national biotechnology ecosystem, excelling in the number of biotech companies, revenue volume, and its ability to attract international investment.
   

AseBio

The Green Innovation Forum 2024 Will analyze the key role of biotechnology in the transition towards a more sustainable economy in Pamplona

04/11/2024

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy

• The fifth edition, organized by AseBio and the Government of Navarra through the public company Sodena, will take place on November 19 at the Baluarte Congress and Auditorium Palace in Navarra.
• The Green Innovation Forum 2024 is a must-attend event for companies, foundations, and academic institutions in the biotechnology field, as well as for companies and institutions from other industrial sectors with an interest in the green economy sector.
• In addition to a comprehensive program of conferences led by a distinguished group of experts, the event will foster the creation of new business and investment opportunities.
• With over 140 registered attendees, we are on track to reach over 300 participants.

AseBio

Biotechnology plays a crucial role in the latest advances against Alzheimer's

21/09/2024

Healthcare · Innovative drugs · Personalized medicine · Advanced therapies

• Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop the progression of the neurodegenerative process nor restore the neuronal damage it has caused.
• Despite the efforts and enormous resources dedicated to the field of Alzheimer's disease, there is currently no approved treatment that cures this condition.
• Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor that has enabled improvements in treatments in recent years.
   

AseBio

Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most common tumor in men and the eighth in women in Spain

15/09/2024

Healthcare · Rare diseases · Innovative drugs · Personalized medicine

• There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and non-Hodgkin lymphoma.
• It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority (approximately 85%) being non-Hodgkin.
• Biotechnology has enabled advances such as diagnosis through next-generation sequencing tools, non-invasive detection methods, the development of targeted therapies, immunotherapy with monoclonal antibodies, and nanotechnology.

AseBio

Biotechnology, at the forefront of the fight against sepsis, one of the world's most serious and deadly conditions, with a 20% mortality rate

13/09/2024

Healthcare · Innovative drugs

• Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 
• 22% of sepsis survivors who have required intensive care suffer from post-traumatic stress disorder, and 17% of survivors experience moderate to severe cognitive impairment. 
• The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
  
   

AseBio